Concordance of biopsy and prostatectomy diagnosis of intraductal and cribriform carcinoma in a prospectively collected data set
- 30 August 2018
- journal article
- research article
- Published by Wiley in Histopathology
- Vol. 74 (3), 474-482
- https://doi.org/10.1111/his.13747
Abstract
Purpose Intraductal and cribriform carcinoma of the prostate are increasingly recognized as independent prognosticators of poor outcome both in prostate biopsies and surgical specimens. We studied the concordance of biopsy and prostatectomy diagnosis for these two sub‐pathologies, in relationship with pathological stage. Materials and Methods Mandatory synoptic reporting of intraductal and cribriform carcinoma in prostate biopsies and prostatectomy specimens was adopted by two academic institutions in November 2015. Synoptic reports of 245 biopsy and corresponding prostatectomy specimens were interrogated to determine the prevalence of intraductal and cribriform carcinoma. Sensitivity and specificity were determined with prostatectomy diagnosis as gold standard. Associations with pathological stage as primary outcome parameter were determined using univariable and multivariable logistic regression analysis. Results Prevalence of the combination of intraductal and cribriform carcinoma was 26.9% in biopsies and 51.8% in prostatectomy specimens. Sensitivity and specificity at biopsy were 47.2% and 94.9%, respectively. Intraductal and cribriform carcinoma at biopsy were associated with advanced pathological stage independent of grade (p=0.013). Among patients with Grade Group 2 prostate cancer at biopsy, the more advanced pathological stage distribution was similar for those with a false negative and a true positive biopsy diagnosis of intraductal and cribriform carcinoma (p=0.29). Conclusion In spite of low sensitivity, intraductal and cribriform carcinoma at biopsy was strongly associated with advanced stage at radical prostatectomy. Since a false negative biopsy diagnosis was equally associated with advanced pathological stage, efforts should be undertaken to improve the sensitivity of biopsy diagnosis for intraductal and cribriform carcinoma.Keywords
Funding Information
- Prostate Cancer Canada.
This publication has 25 references indexed in Scilit:
- Diagnosis of “Poorly Formed Glands” Gleason Pattern 4 Prostatic Adenocarcinoma on Needle BiopsyThe American Journal of Surgical Pathology, 2015
- Active surveillance for the management of localized prostate cancer: Guideline recommendationsCanadian Urological Association Journal, 2015
- Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancerLaboratory Investigation, 2015
- Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologistsAnnals of Diagnostic Pathology, 2014
- Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohortEuropean Journal of Cancer, 2014
- Incidence and clinicopathological characteristics of intraductal carcinoma detected in prostate biopsies: a prospective cohort studyHistopathology, 2013
- Intraductal carcinoma of the prostate: Precursor or aggressive phenotype of prostate cancer?The Prostate, 2012
- Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapyEuropean Journal of Cancer, 2012
- Digital Quantification of Five High-Grade Prostate Cancer Patterns, Including the Cribriform Pattern, and Their Association With Adverse OutcomeAmerican Journal of Clinical Pathology, 2011
- Outcomes of Active Surveillance for Men With Intermediate-Risk Prostate CancerJournal of Clinical Oncology, 2011